Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 886

1.

Rebound insomnia after hypnotic withdrawal in insomniac outpatients.

Hajak G, Clarenbach P, Fischer W, Rodenbeck A, Bandelow B, Broocks A, Rüther E.

Eur Arch Psychiatry Clin Neurosci. 1998;248(3):148-56.

PMID:
9728734
2.

Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo.

Hajak G, Clarenbach P, Fischer W, Haase W, Rüther E.

Int Clin Psychopharmacol. 1994 Winter;9(4):251-61.

PMID:
7868847
3.
4.

A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.

Voderholzer U, Riemann D, Hornyak M, Backhaus J, Feige B, Berger M, Hohagen F.

Eur Arch Psychiatry Clin Neurosci. 2001 Jun;251(3):117-23.

PMID:
11697572
5.

Nighttime versus daytime hypnotic self-administration.

Roehrs T, Bonahoom A, Pedrosi B, Zorick F, Roth T.

Psychopharmacology (Berl). 2002 May;161(2):137-42. Epub 2002 Mar 14.

PMID:
11981593
6.

Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety.

Fontaine R, Beaudry P, Le Morvan P, Beauclair L, Chouinard G.

Int Clin Psychopharmacol. 1990 Jul;5(3):173-83.

PMID:
2230061
7.

Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs.

Elie R, Frenay M, Le Morvan P, Bourgouin J.

Int Clin Psychopharmacol. 1990 Apr;5 Suppl 2:39-46.

PMID:
2201729
10.

Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.

Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, Berger M, Rüther E.

J Clin Psychiatry. 2001 Jun;62(6):453-63.

PMID:
11465523
11.

Zolpidem for persistent insomnia in SSRI-treated depressed patients.

Asnis GM, Chakraburtty A, DuBoff EA, Krystal A, Londborg PD, Rosenberg R, Roth-Schechter B, Scharf MB, Walsh JK.

J Clin Psychiatry. 1999 Oct;60(10):668-76.

PMID:
10549683
12.

Chronic administration of zopiclone and nitrazepam in the treatment of insomnia.

Tamminen T, Hansen PP.

Sleep. 1987;10 Suppl 1:63-72.

PMID:
3326117
13.

A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.

Fleming JA, McClure DJ, Mayes C, Phillips R, Bourgouin J.

Int Clin Psychopharmacol. 1990 Apr;5 Suppl 2:29-37.

PMID:
2201728
14.

An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.

Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.

Sleep Med. 2005 Nov;6(6):487-95. Epub 2005 Oct 17.

PMID:
16230048
15.

[Treatment of insomnia related to depressive disorders. Effects of zolpidem versus flunitrazepam administration and withdrawal evaluated in a double-blind study].

Guazzelli M, Ciapparelli A, Balsamo EL, Gemignani A, Sarteschi P.

Minerva Psichiatr. 1993 Sep;34(3):193-203. Italian.

PMID:
8302193
16.

Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia.

Zammit GK, McNabb LJ, Caron J, Amato DA, Roth T.

Curr Med Res Opin. 2004 Dec;20(12):1979-91.

PMID:
15701215
17.
18.

Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.

Mouret J, Ruel D, Maillard F, Bianchi M.

Int Clin Psychopharmacol. 1990 Apr;5 Suppl 2:47-55.

PMID:
2201730
19.

Effect of midazolam, flunitrazepam, and placebo against midwinter insomnia in northern Norway.

Lingjaerde O, Bratlid T, Westby OC, Gordeladze JO.

Acta Psychiatr Scand. 1983 Feb;67(2):118-29.

PMID:
6133412
20.

Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.

Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R.

Arch Gen Psychiatry. 2008 May;65(5):551-62. doi: 10.1001/archpsyc.65.5.551.

PMID:
18458207

Supplemental Content

Support Center